Status:
COMPLETED
Study on Prediction of Left Ventricular Remodeling Using ST2
Lead Sponsor:
Keimyung University Dongsan Medical Center
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
19+ years
Brief Summary
Patients who underwent percutaneous coronary intervention after diagnosis of acute coronary syndrome should be enrolled in the study and follow - up.
Detailed Description
Obtain written consent for patients who meet all of the selection criteria and who do not meet the exclusion criteria. ACS(Acute Coronary Syndrome) patients with LV systolic dysfunction(LVEF\<50%) on...
Eligibility Criteria
Inclusion
- Subjects aged 19 or older
- Patients with acute coronary syndrome who underwent successful percutaneous coronary intervention
- Patients with left ventricular ejection fraction less than 50% on transthoracic echocardiography
- Patients who voluntarily agreed to participate in the study
Exclusion
- Failure to obtain TIMI 3 flow after procedure
- If the remaining life span is less than one year
- Women who are breastfeeding or plan to become pregnant or are planning to become pregnant during the study period
Key Trial Info
Start Date :
February 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT03841214
Start Date
February 25 2019
End Date
June 30 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Keimyung University Dongsan Hospital
Daegu, Dalseogu, South Korea, 42601